Skip to main content
Clinical Trials/ACTRN12618001320246
ACTRN12618001320246
Completed
N/A

OPtimisation of Perioperative Cardiovascular Management to Improve Surgical outcomE II trial (Optimise II) - biomarker sub-study for Australian sites

St Vincent's Hospital Melbourne0 sites103 target enrollmentAugust 6, 2018

Overview

Phase
N/A
Intervention
Not specified
Conditions
Postoperative infection
Sponsor
St Vincent's Hospital Melbourne
Enrollment
103
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 6, 2018
End Date
October 12, 2022
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
St Vincent's Hospital Melbourne

Eligibility Criteria

Inclusion Criteria

  • Patients who have consented and recruited to the OptimiseII trial which includes
  • patients aged 65 years and over undergoing major elective surgery involving the gastrointestinal tract that is expected to take longer than 90 minutes.

Exclusion Criteria

  • Inability or refusal to provide patient consent
  • clinician refusal (including intention to monitor cardiac output from the start of surgery regardless of study group allocation)
  • American Society of Anesthesiologists (ASA) score of I
  • patients expected to die within 30 days
  • acute myocardial ischaemia within 30 days prior to randomisation
  • acute pulmonary oedema within 30 days prior to randomisation
  • contra\-indication to low\-dose inotropic medication
  • pregnancy at time of enrolment
  • current participation in another clinical trial of a treatment with a similar biological mechanism or primary outcome measure

Outcomes

Primary Outcomes

Not specified

Similar Trials